Literature DB >> 33174099

Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China.

Parbatraj Regmi1, Hai-Jie Hu1, Yin Chang-Hao1, Fei Liu1, Wen-Jie Ma1, Cong-Dun Ran1, Jun-Ke Wang1, Aliza Paudyal1, Nan-Sheng Cheng1, Fu-Yu Li2.   

Abstract

BACKGROUND: Surgical treatment is still the most effective treatment for gallbladder cancer. For the patients with stage T1b and above, the current guidelines recommend the extended radical operation, and oncologic extended resection can benefit the survival of the patients. The laparoscopic approach is still in the early phase, and its safety and oncological outcomes are not well known.
OBJECTIVE: To evaluate the technical feasibility and oncological outcomes of laparoscopic surgery for oncologic extended resection of early-stage incidental gallbladder carcinoma.
RESULTS: This study included 18 male and 32 female patients. Twenty patients underwent laparoscopic oncologic extended resection and 30 patients underwent open oncologic extended resection. All of the patients had R0 resection. A laparoscopic approach was associated with less intraoperative blood loss (242 ± 108.5 vs 401 ± 130.3; p < 0.01) and shorter duration of postoperative hospital stay (6.2 ± 2.4 vs 8.6 ± 2.3; p < 0.01). There was no statistically significant difference between two groups for lymph nodes yield (5.4 ± 3.5 vs 5.8 ± 2.1; p > 0.05), incidence of lymphatic metastasis (15% vs 16.67%; p > 0.05), residual disease (20% vs 23.3%; p > 0.05), and postoperative morbidity (15% vs 20%; p > 0.05). During follow-up time of median 20.95 (12-29.5) months, no significant difference was found between the two groups for early tumor recurrence (10% vs 13.33%; p > 0.05) and disease-free survival (p > 0.05).
CONCLUSION: Laparoscopic surgery may offer similar intraoperative, perioperative, and short-term oncological outcomes as an open oncologic extended resection for incidental gallbladder carcinoma.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Incidental gallbladder carcinoma; Laparoscopic surgery; Oncologic extended resection

Mesh:

Year:  2020        PMID: 33174099     DOI: 10.1007/s00464-020-08146-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  46 in total

1.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  Laparoscopy versus laparotomy approach of a radical resection for gallbladder cancer: a retrospective comparative study.

Authors:  Changwei Dou; Yuhua Zhang; Jie Liu; Fangqiang Wei; Hongwu Chu; Junjun Han; Qifeng Yao; Jianyi Ding; Chengwu Zhang
Journal:  Surg Endosc       Date:  2019-08-28       Impact factor: 4.584

3.  Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.

Authors:  Eduardo A Vega; Eduardo Vinuela; Masayuki Okuno; Katharina Joechle; Marcel Sanhueza; Cristian Diaz; Nicolas Jarufe; Jorge Martinez; Andres Troncoso; Alfonso Diaz; Yun S Chun; Ching-Wei D Tzeng; Jeffrey E Lee; Jean-Nicolas Vauthey; Claudius Conrad
Journal:  HPB (Oxford)       Date:  2019-01-31       Impact factor: 3.647

4.  Incidental Gallbladder Carcinoma Discovered after Laparoscopic Cholecystectomy: Identifying Patients Who will Benefit from Reoperation.

Authors:  Pietro Addeo; Leonardo Centonze; Andrea Locicero; François Faitot; Hissam Jedidi; Emanuele Felli; Pascal Fuchshuber; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2017-12-22       Impact factor: 3.452

Review 5.  Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review.

Authors:  David Berger-Richardson; Tyler R Chesney; Marina Englesakis; Anand Govindarajan; Sean P Cleary; Carol J Swallow
Journal:  Surgery       Date:  2016-10-13       Impact factor: 3.982

6.  Systematic review of management of incidental gallbladder cancer after cholecystectomy.

Authors:  K Søreide; R V Guest; E M Harrison; T J Kendall; O J Garden; S J Wigmore
Journal:  Br J Surg       Date:  2019-01       Impact factor: 6.939

7.  Does a second resection provide a survival benefit in patients diagnosed with incidental T1b/T2 gallbladder cancer following cholecystectomy?

Authors:  Henry Watson; Bobby Dasari; Judy Wyatt; Ernest Hidalgo; Raj Prasad; Peter Lodge; Giles Toogood
Journal:  HPB (Oxford)       Date:  2016-12-13       Impact factor: 3.647

8.  Laparoscopic approach for suspected early-stage gallbladder carcinoma.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Keun Soo Ahn; Young-Hoon Kim; Kyoung-Ho Lee
Journal:  Arch Surg       Date:  2010-02

9.  Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.

Authors:  David Fuks; Jean Marc Regimbeau; Yves-Patrice Le Treut; Philippe Bachellier; Artivas Raventos; François-René Pruvot; Laurence Chiche; Olivier Farges
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

10.  Gallbladder cancer: the role of laparoscopy and radical resection.

Authors:  Samuel P Shih; Richard D Schulick; John L Cameron; Keith D Lillemoe; Henry A Pitt; Michael A Choti; Kurtis A Campbell; Charles J Yeo; Mark A Talamini
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  3 in total

1.  A Novel Clinically Prognostic Stratification Based on Prognostic Nutritional Index Status and Histological Grade in Patients With Gallbladder Cancer After Radical Surgery.

Authors:  Peng Cao; Haijie Hong; Zijian Yu; Guodong Chen; Shuo Qi
Journal:  Front Nutr       Date:  2022-05-04

2.  Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer.

Authors:  Jiasheng Cao; Yong Wang; Bin Zhang; Jiahao Hu; Win Topatana; Shijie Li; Sarun Juengpanich; Ziyi Lu; Xiujun Cai; Mingyu Chen
Journal:  Front Oncol       Date:  2021-10-28       Impact factor: 6.244

3.  HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.

Authors:  Yizhou Zhang; Hanrong Li; Chao Lv; Baokang Wu; Yang Yu; Chongli Zhong; Qi Lang; Zhiyun Liang; Yang Li; Yu Shi; Jian Zhang; Feng Xu; Yu Tian
Journal:  Int J Oncol       Date:  2022-08-03       Impact factor: 5.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.